Prostarm Info Systems Limited: Trading Window Closed from Oct 1, 2026 for Q2 FY27 Results
Prostarm Info Systems Limited will close its trading window from October 1, 2026, until 48 hours after the declaration of Q2 FY27 financial results. This affects Designated Persons and their relatives, prohibiting them from trading in company shares during this period.
The closure of the trading window is a standard procedural requirement for listed companies and is a routine event. It does not directly impact the company's operations or financial performance and is a common practice before the announcement of financial results.
The announcement is a standard regulatory disclosure regarding the closure of the trading window, which is a routine procedure before financial results are announced. It does not contain any new financial information or operational updates that would indicate a positive or negative sentiment.
Prostarm Info Systems Limited has announced the closure of its trading window for all Designated Persons and their Immediate Relatives. This closure will be effective from Thursday, October 01, 2026, and will remain in effect until 48 hours after the declaration of the un-audited financial results for the Quarter and Half Year ended September 30, 2026.
All Designated Persons, their Immediate Relatives, and other Insiders are advised not to engage in any dealings related to the company's equity shares during this period. The company will inform the stock exchanges in due course about the date of the Board Meeting where the financial results will be approved.
The intimation is in compliance with the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015, as amended, and the Company's internal code for the prevention of insider trading. This information will also be available on the company's website, www.prostarm.com.
What to do with a filing like this
Prostarm Info Systems Limited filed this with the NSE as a statutory disclosure, categorised under trading window disclosure. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Prostarm Info Systems Limited. Read the original for the full detail.